{"id":"NCT02143648","sponsor":"Trevi Therapeutics","briefTitle":"Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel, 3-Arm Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2014-06","primaryCompletion":"2015-07","completion":"2015-07","firstPosted":"2014-05-21","resultsPosted":"2020-09-07","lastUpdate":"2025-05-21"},"enrollment":373,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Uremic Pruritus","Pruritus"],"interventions":[{"type":"DRUG","name":"nalbuphine HCl ER tablets 60 mg BID","otherNames":["nalbuphine ER"]},{"type":"DRUG","name":"nalbuphine HCl ER tablets 120mg BID","otherNames":["nalbuphine ER"]},{"type":"DRUG","name":"Placebo tablets BID","otherNames":["sugar pill"]}],"arms":[{"label":"nalbuphine HCl ER 60mg","type":"EXPERIMENTAL"},{"label":"nalbuphine HCl ER 120mg","type":"EXPERIMENTAL"},{"label":"Sugar pill","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objectives of the study to evaluate the effects of two doses of nalbuphine HCl ER tablets on the change from baseline in the worst itch Numerical Rating Scale (NRS) in hemodialysis patients with moderate to severe uremic pruritus and to evaluate the safety and tolerability in the study population.","primaryOutcome":{"measure":"Change From Baseline to the Evaluation Period in Itch on the 0-10 Itch Numerical Rating Scale","timeFrame":"8 weeks","effectByArm":[{"arm":"Nalbuphine HCl ER 60mg","deltaMin":-3.1,"sd":2.35},{"arm":"Nalbuphine HCl ER 120mg","deltaMin":-3.49,"sd":2.37},{"arm":"Sugar Pill","deltaMin":-2.8,"sd":2.22}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":47,"countries":["United States","Poland","Romania"]},"refs":{"pmids":["33283264"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":126},"commonTop":[]}}